Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nirogacestat in Japanese Adults With Progressing Desmoid Tumors
NCT07170644Phase 2Active, not recruiting
- Sponsor
- SpringWorks Therapeutics
- Start
- Aug 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nirogacestat in desmoid tumor, sponsored by SpringWorks Therapeutics. Started Aug 2025; status: active, not recruiting.
02
Drugs
nirogacestat
03
Conditions
desmoid tumor
Beyond the preview
Go deeper on NCT07170644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07170644.